Cite
HARVARD Citation
Chaftari, A. et al. (n.d.). 293. Lung Cancer and Hematologic Malignancy ( HM) Patients Are Associated with the Highest Risk of Progressing to Severe Disease and Mortality in Cancer Patients with COVID-19. Open forum infectious diseases. p. S254. [Online].